| [1] |
He S, Stankowska DL, Ellis DZ,et al.Targets of neuroprotection in glaucoma[J].J Ocul Pharmacol Ther,2018,34(1-2):85-106.
|
| [2] |
Bluwol E.Glaucoma treatment[J].Rev Prat,2016,66(5):508-513.
|
| [3] |
Weinreb RN, Aung T, Medeiros FA.The pathophysiology and treatment of glaucoma: a review[J].JAMA,2014,311(18):1901-1911.
|
| [4] |
Geyer O, Bottone EJ, Podos SM,et al.Microbial contamination of medications used to treat glaucoma[J].Br J Ophthalmol,1995,79(4):376-379.
|
| [5] |
Jokl DH, Wormser GP, Nichols NS,et al.Bacterial contamination of ophthalmic solutions used in an extended care facility[J].Br J Ophthalmol,2007,91(10):1308-1310.
|
| [6] |
Kyei S, Appiah E, Ayerakwa EA.Microbial safety implications of in-use topical diagnostic ophthalmic medications in eye clinics in Ghana[J].J Optom,2019,12(4):263-271.
|
| [7] |
Porges Y, Rothkoff L, Glick J,et al.Sterility of glaucoma medications among chronic users in the community[J].J Ocul Pharmacol Ther,2004,20(2):123-128.
|
| [8] |
Tamrat L, Gelaw Y, Beyene G,et al.Microbial contamination and antimicrobial resistance in use of ophthalmic solutions at the Department of Ophthalmology, Jimma University Specialized Hospital, Southwest Ethiopia[J].Can J Infect Dis Med Microbiol,2019:5372530.
|
| [9] |
Stevens JD, Matheson MM.Survey of the contamination of eyedrops of hospital inpatients and recommendations for the changing of current practice in eyedrop dispensing[J].Br J Ophthalmol,1992,76(1):36-38.
|
| [10] |
Tsegaw A, Tsegaw A, Abula T,et al.Bacterial contamination of multi-dose eye drops at Ophthalmology Department, University of Gondar, Northwest Ethiopia[J].Middle East Afr J Ophthalmol,2017,24(2):81-86.
|
| [11] |
Mah-Sadorra JH, Najjar DM, Rapuano CJ,et al.Serratia corneal ulcers: a retrospective clinical study[J].Cornea,2005,24(7):793-800.
|
| [12] |
Penland RL, Wilhelmus KR.Stenotrophomonas maltophilia ocular infections[J].Arch Ophthalmol,1996,114(4):433-436.
|
| [13] |
Teuchner B, Wagner J, Bechrakis NE,et al.Microbial contamination of glaucoma eyedrops used by patients compared with ocular medications used in the hospital[J].Medicine (Baltimore),2015,94(8):e583.
|
| [14] |
Fazeli MR, Nejad HB, Mehrgan H,et al.Microbial contamination of preserved ophthalmic drops in outpatient departments: possibility of an extended period of use[J].DARU J Pharmaceut Sci,2004,12:151-155.
|
| [15] |
Clark PJ, Ong B, Stanley CB.Contamination of diagnostic ophthalmic solutions in primary eye care settings[J].Mil Med,1997,162(7):501-506.
|
| [16] |
Nentwich MM, Kollmann KH, Meshack J,et al.Microbial contamination of multi-use ophthalmic solutions in Kenya[J].Br J Ophthalmol,2007,91(10):1265-1268.
|
| [17] |
Brudieu E, Duc DL, Masella JJ,et al.Bacterial contamination of multi-dose ocular solutions. A prospective study at the Grenoble Teaching Hospital[J].Pathol Biol (Paris),1999,47(10):1065-1070.
|
| [18] |
Schein OD, Wasson PJ, Boruchoff SA,et al.Microbial keratitis associated with contaminated ocular medications[J].Am J Ophthalmol,1988,105(4):361-365.
|
| [19] |
Feghhi M, Mahmoudabadi AZ, Mehdinejad M.Evaluation of fungal and bacterial contaminations of patient used ocular drops[J].Med Mycol,2008,46(1):17-21.
|
| [20] |
Kyei S, France D, Asiedu K.Microbial contamination of multiple-use bottles of fluorescein ophthalmic solution[J].Clin Exp Optom,2019,102(1):30-34.
|
| [21] |
Rahman MQ, Tejwani D, Wilson JA,et al.Microbial contamination of preservative free eye drops in multiple application containers[J].Br J Ophthalmol,2006,90(2):139-141.
|
| [22] |
Perry HD, Donnenfeld ED.Issues in the use of preservative free topicals[J].Manag Care,2003,12:39-41.
|
| [23] |
Kaur IP, Lal S, Rana C,et al.Ocular preservatives: associated risks and newer options[J].Cutan Ocul Toxicol,2009,28(3):93-103.
|
| [24] |
Furrer P, Mayer JM, Gurny R.Ocular tolerance of preservatives and alternatives[J].Eur J Pharm Biopharm,2002,53(3):263-280.
|
| [25] |
Epstein SP, Ahdoot M, Marcus E,et al.Comparative toxicity of preservatives on immortalized corneal and conjunctival epithelial cells[J].J Ocul Pharmacol Ther,2009,25(2):113-119.
|
| [26] |
Pisella PJ, Fillacier K, Elena PP,et al.Comparison of the effectsof preserved and unpreserved formulations of timolol on theocular surface of albino rabbits[J].Ophthalmic Res,2000,32(1):3-8.
|
| [27] |
Tripathi BJ, Tripathi RC.Cytotoxic effects of benzalkoniumchloride and chlorobutanol on human corneal epithelial cellsin vitro[J].Lens Eye Toxic Res,1989,6(3):395-403.
|
| [28] |
Stone JL, Robin AL, Novack GD,et al.An objective evaluation of eyedrop instillation in patients with glaucoma[J].Arch Ophthalmol,2009,127(6):732-736.
|
| [29] |
Taᶊli H, Coᶊar G.Microbial contamination of eye drops[J].Cent Eur J Public Health,2001,9(3):162-164.
|
| [30] |
Raynaud C, Laveran H, Rigal D,et al.Bacterial contamination of eyedrops in clinical use[J].J Fr phtalmol,1997,20(1):17-24.
|
| [31] |
Saisyo A, Shimono R, Oie S,et al.The risk of microbial contamination in multiple-dose preservative-free ophthalmic preparations[J].Biol Pharm Bull,2017,40(2):182-186.
|
| [32] |
Choy BNK, Zhu MM, Pang JCS,et al.Factors associated with poor eye drop administration technique and the role of patient education among Hong Kong elderly population[J].J Ophthalmol,2019,26:5962065.
|
| [33] |
Hosoda M, Yamabayashi S, Furuta M,et al.Do glaucoma patients use eye drops correctly？[J].J Glaucoma,1995,4(3):202-206.
|
| [34] |
Aptel F, Masset H, Burillon C,et al.The influence of disease severity on quality of eye-drop administration in patients with glaucoma or ocular hypertension[J].Br J Ophthalmol,2009,93(5):700-701.
|
| [35] |
Gao X, Yang Q, Huang W,et al.Evaluating eye drop instillation technique and its determinants in glaucoma patients[J].J Ophthalmol,2018:1376020.
|
| [36] |
Schneider KJ, Hollenhorst CN, Valicevic AN,et al.Impact of the support, educate, empower personalized glaucoma coaching program pilot study on eye drop instillation technique and self-efficacy[J].Ophthalmol Glaucoma,2021,4(1):42-50.
|
| [37] |
Su CY, Yang YC, Peng CF,et al.Risk of microbial contamination of unit-dose eyedrops within twenty four hours after first opening[J].J Formos Med Assoc,2005,104(12):968-971.
|
| [38] |
Oldham GB, Andrews V.Control of microbial contamination in unpreserved eyedrops[J].Br J Ophthalmol,1996,80(7):588-591.
|
| [39] |
Costa AXD, Yu MCZ, Freitas DD,et al.Microbial cross-contamination in multidose eyedrops: the impact of instillation angle and bottle geometry[J].Transl Vis Sci Technol,2020,9(7):7.
|
| [40] |
Davies IJ, Brown NH, Wen JC,et al.An upright eyedrop bottle: accuracy, usage of excess drops, and contamination compared to a conventional bottle[J].Clin Ophthalmol,2016,10:1411-1417.
|
| [41] |
Davies I, Williams AM, Muir KW.Aids for eye drop administration[J].Surv Ophthalmol,2017,62(3):332-345.
|
| [42] |
Salyani A, Birt C.Evaluation of an eye drop guide to aid self-administration by patients experienced with topical use of glaucoma medication[J].Can J Ophthalmol,2005,40(2):170-174.
|
| [43] |
Strungaru MH, Peck J, Compeau EC,et al.Mirror-hat device as a drop delivery aid: a pilot study[J].Can J Ophthalmol,2014,49(4):333-338.
|